Management of Attention-Deficit Hyperactivity Disorder with a Focus on Pharmacogenetics

Join Genomind Medical Science Liaisons, Dr. Russell Amato, PhD and Dr. Seema Patel, PharmD, as they present on the management of attention-deficit hyperactivity disorder (ADHD). They discuss various treatment options and associated evidence, as well as highlight pharmacogenetic considerations in the management of this challenging clinical presentation.